<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03610009</url>
  </required_header>
  <id_info>
    <org_study_id>SonoAVC</org_study_id>
    <nct_id>NCT03610009</nct_id>
  </id_info>
  <brief_title>2D Versus SonoAVC Scanning in High Responders</brief_title>
  <official_title>Manual Versus Automated Measurements of Ovarian Follicle Diameter in High Responding Patients With GnRH Agonist Triggering of Final Oocyte Maturation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eugonia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eugonia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Accurate follicular monitoring of Controlled Ovarian Stimulation by transvaginal ultrasound
      is considered important for the success of human in vitro fertilization (IVF). The aim of
      this study is to evaluate the effect of timing oocyte maturation and egg collection on the
      basis of follicular measurements made automatically with Sono Automated Volume Calculation
      (SonoAVC) against those made with conventional 2D ultrasound in relation to the number of
      mature oocytes collected.

      This study will take place in women undergoing IVF who are high responders (&gt;=14
      follicles&gt;=11mm) and hence at risk for developing ovarian hyperstimulation syndrome (OHSS),
      treated with a GnRH antagonist protocol and administered GnRH agonist to trigger final oocyte
      maturation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Accurate follicular monitoring of Controlled Ovarian Stimulation by transvaginal ultrasound
      is considered important for the success of human in vitro fertilization (IVF). Accurate
      assessment of the size of follicles is important for the timing of oocyte maturation and
      subsequent oocyte retrieval.

      Serial assessment of follicle number and size is used routinely to assess the response to
      ovarian stimulation during assisted reproduction treatment (ART). Two-dimensional (2D)
      ultrasound is used to identify and scroll through each ovary while the observer quantifies
      the number of follicles present. An objective assessment of the size of the larger follicles,
      commonly those measuring &gt;10 mm, is then made through a series of 2D measurements of their
      perceived mean diameter.

      Sono Automated Volume Calculation (SonoAVC; GE Medical Systems) is a new software program
      that can be applied to datasets acquired with use of threedimensional (3D) ultrasound. It
      individually identifies and quantifies the size of any hypoechoic region within these 3D
      datasets, providing an automatic estimation of their absolute dimensions and volume. SonoAVC
      is an ideal and, potentially, a clinically important tool for the assessment and measurement
      of follicles during controlled ovarian stimulation because each hypoechoic area is
      individually color coded, thereby eliminating the possibility of measuring the same follicle
      more than once.

      In women with high ovarian response to gonadotrophin stimulation, the accurate measurement of
      the number and size of follicles present in hyperstimulated ovaries is a challenge for
      clinicians and ultrasonographers.

      The aim of this study is to evaluate the effect of timing final oocyte maturation trigger and
      egg collection on the basis of follicular measurements made automatically with SonoAVC
      against those made with conventional 2D ultrasound in relation to the number of mature
      oocytes collected. This study will include women undergoing ART who are high responders
      (presence of =&gt;14 follicles&gt;=11mm) and hence at risk for developing ovarian hyperstimulation
      syndrome (OHSS), treated with a GnRH antagonist protocol and are administered GnRH agonist to
      trigger final oocyte maturation. All resulting embryos (blastocysts) will be cryopreserved
      and transferred in a subsequent frozen cycle.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2019</completion_date>
  <primary_completion_date type="Actual">January 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Follicle development in women undergoing IVF will be monitored either by conventional 2D ultrasound or SonoAVC.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Women (patients), clinician performing oocyte retrieval and clinical embryologist will be blinded to the method used for monitoring follicle development</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of mature oocytes</measure>
    <time_frame>Day of oocyte retrieval</time_frame>
    <description>The number of mature (metaphase-II) oocytes retrieved</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of oocytes retrieved</measure>
    <time_frame>Day of oocyte retrieval</time_frame>
    <description>Total number of oocytes retrieved</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oocyte maturation rate</measure>
    <time_frame>Day of oocyte retrieval</time_frame>
    <description>Percentage of mature oocytes/total number of oocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oocyte retrieval rate</measure>
    <time_frame>Day of oocyte retrieval</time_frame>
    <description>Percentage of oocyte retrieved/number of follicles aspirated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of fertilised oocytes</measure>
    <time_frame>1 day post oocyte retrieval</time_frame>
    <description>Number of fertilised oocytes displaying 2 pronuclei and 2 polar bodies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fertilisation rate</measure>
    <time_frame>1 day post oocyte retrieval</time_frame>
    <description>Percentage fertilised oocytes/oocytes inseminated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of blastocysts</measure>
    <time_frame>5 days post oocyte retrieval</time_frame>
    <description>Number of embryos reaching the blastocyst stage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of stimulation</measure>
    <time_frame>10-15 days after menses</time_frame>
    <description>Number of days recFSH is administered</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose of recFSH</measure>
    <time_frame>10-15 days after menses</time_frame>
    <description>Total dose of recFSH administered during the ovarian stimulation period</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>2D ultrasound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two-dimensional (2D) ultrasound is used to identify number and size of ovarian follicles, to select optimal day for triggering final oocyte maturation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SonoAVC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SonoAVC is used to identify number and size of ovarian follicles, to select optimal day for triggering final oocyte maturation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2D ultrasound</intervention_name>
    <description>The timing of final follicle maturation and oocyte retrieval based on follicle tracking with use of conventional two-dimensional (2D) ultrasound.</description>
    <arm_group_label>2D ultrasound</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SonoAVC</intervention_name>
    <description>The timing of final follicle maturation and oocyte retrieval based on follicle tracking with use of SonoAVC.</description>
    <arm_group_label>SonoAVC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AMH &gt;= 3ng/ml

          -  at least 14 follicles =&gt;11 mm diameter on final day of stimulation

          -  undergoing GnRH antagonist protocol

          -  administered GnRH agonist to trigger final oocyte maturation

        Exclusion Criteria:

          -  poor responders

          -  hCG injection to trigger final oocyte maturation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tryfon Lainas, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Eugonia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eugonia Unit of Assisted Reproduction</name>
      <address>
        <city>Athens</city>
        <zip>11528</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Raine-Fenning N, Deb S, Jayaprakasan K, Clewes J, Hopkisson J, Campbell B. Timing of oocyte maturation and egg collection during controlled ovarian stimulation: a randomized controlled trial evaluating manual and automated measurements of follicle diameter. Fertil Steril. 2010 Jun;94(1):184-8. doi: 10.1016/j.fertnstert.2009.02.063. Epub 2009 Apr 1.</citation>
    <PMID>19342014</PMID>
  </reference>
  <reference>
    <citation>Lamazou F, Arbo E, Salama S, Grynberg M, Frydman R, Fanchin R. Reliability of automated volumetric measurement of multiple growing follicles in controlled ovarian hyperstimulation. Fertil Steril. 2010 Nov;94(6):2172-6. doi: 10.1016/j.fertnstert.2010.01.062. Epub 2010 Mar 12.</citation>
    <PMID>20226448</PMID>
  </reference>
  <reference>
    <citation>Salama S, Arbo E, Lamazou F, Levailllant JM, Frydman R, Fanchin R. Reproducibility and reliability of automated volumetric measurement of single preovulatory follicles using SonoAVC. Fertil Steril. 2010 Apr;93(6):2069-73. doi: 10.1016/j.fertnstert.2008.12.115. Epub 2009 Apr 1.</citation>
    <PMID>19342038</PMID>
  </reference>
  <reference>
    <citation>Ata B, Seyhan A, Reinblatt SL, Shalom-Paz E, Krishnamurthy S, Tan SL. Comparison of automated and manual follicle monitoring in an unrestricted population of 100 women undergoing controlled ovarian stimulation for IVF. Hum Reprod. 2011 Jan;26(1):127-33. doi: 10.1093/humrep/deq320. Epub 2010 Nov 26.</citation>
    <PMID>21112951</PMID>
  </reference>
  <reference>
    <citation>Rodríguez-Fuentes A, Hernández J, García-Guzman R, Chinea E, Iaconianni L, Palumbo A. Prospective evaluation of automated follicle monitoring in 58 in vitro fertilization cycles: follicular volume as a new indicator of oocyte maturity. Fertil Steril. 2010 Feb;93(2):616-20. doi: 10.1016/j.fertnstert.2009.02.058. Epub 2009 Apr 18.</citation>
    <PMID>19376513</PMID>
  </reference>
  <reference>
    <citation>Revelli A, Martiny G, Delle Piane L, Benedetto C, Rinaudo P, Tur-Kaspa I. A critical review of bi-dimensional and three-dimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome? Reprod Biol Endocrinol. 2014 Nov 24;12:107. doi: 10.1186/1477-7827-12-107. Review.</citation>
    <PMID>25420733</PMID>
  </reference>
  <reference>
    <citation>Deb S, Campbell BK, Clewes JS, Raine-Fenning NJ. Quantitative analysis of antral follicle number and size: a comparison of two-dimensional and automated three-dimensional ultrasound techniques. Ultrasound Obstet Gynecol. 2010 Mar;35(3):354-60. doi: 10.1002/uog.7505.</citation>
    <PMID>20069654</PMID>
  </reference>
  <reference>
    <citation>Deutch TD, Joergner I, Matson DO, Oehninger S, Bocca S, Hoenigmann D, Abuhamad A. Automated assessment of ovarian follicles using a novel three-dimensional ultrasound software. Fertil Steril. 2009 Nov;92(5):1562-8. doi: 10.1016/j.fertnstert.2008.08.102. Epub 2008 Oct 19.</citation>
    <PMID>18937942</PMID>
  </reference>
  <reference>
    <citation>Vandekerckhove F, Bracke V, De Sutter P. The Value of Automated Follicle Volume Measurements in IVF/ICSI. Front Surg. 2014 May 28;1:18. doi: 10.3389/fsurg.2014.00018. eCollection 2014. Review.</citation>
    <PMID>25593942</PMID>
  </reference>
  <reference>
    <citation>Pan P, Chen X, Li Y, Zhang Q, Zhao X, Bodombossou-Djobo MM, Yang D. Comparison of manual and automated measurements of monodominant follicle diameter with different follicle size in infertile patients. PLoS One. 2013 Oct 10;8(10):e77095. doi: 10.1371/journal.pone.0077095. eCollection 2013.</citation>
    <PMID>24130840</PMID>
  </reference>
  <reference>
    <citation>Raine-Fenning N, Jayaprakasan K, Chamberlain S, Devlin L, Priddle H, Johnson I. Automated measurements of follicle diameter: a chance to standardize? Fertil Steril. 2009 Apr;91(4 Suppl):1469-72. doi: 10.1016/j.fertnstert.2008.07.1719. Epub 2008 Oct 18.</citation>
    <PMID>18930205</PMID>
  </reference>
  <reference>
    <citation>Raine-Fenning N, Jayaprakasan K, Clewes J, Joergner I, Bonaki SD, Chamberlain S, Devlin L, Priddle H, Johnson I. SonoAVC: a novel method of automatic volume calculation. Ultrasound Obstet Gynecol. 2008 Jun;31(6):691-6. doi: 10.1002/uog.5359.</citation>
    <PMID>18484679</PMID>
  </reference>
  <reference>
    <citation>Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010 Aug;94(3):1044-51. doi: 10.1016/j.fertnstert.2009.04.040. Epub 2009 Jul 8. Review.</citation>
    <PMID>19589513</PMID>
  </reference>
  <reference>
    <citation>Soldevila PN, Carreras O, Tur R, Coroleu B, Barri PN. Sonographic assessment of ovarian reserve. Its correlation with outcome of in vitro fertilization cycles. Gynecol Endocrinol. 2007 Apr;23(4):206-12.</citation>
    <PMID>17505940</PMID>
  </reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>July 24, 2018</study_first_submitted>
  <study_first_submitted_qc>July 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2018</study_first_posted>
  <last_update_submitted>February 7, 2019</last_update_submitted>
  <last_update_submitted_qc>February 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

